Next Article in Journal
Highlights on the Luspatercept Treatment in Thalassemia
Previous Article in Journal
CRISPR Gene Therapy: A Promising One-Time Therapeutic Approach for Transfusion-Dependent β-Thalassemia—CRISPR-Cas9 Gene Editing for β-Thalassemia
Previous Article in Special Issue
Juggling between the Cost and Value of New Therapies: Does Science Still Serve Patient Needs?
 
 
Article

Article Versions Notes

Thalass. Rep. 2023, 13(1), 70-76; https://doi.org/10.3390/thalassrep13010007
Action Date Notes Link
article pdf uploaded. 16 February 2023 08:49 CET Version of Record https://www.mdpi.com/2039-4365/13/1/7/pdf-vor
article xml file uploaded 17 February 2023 07:58 CET Original file -
article xml uploaded. 17 February 2023 07:58 CET Update https://www.mdpi.com/2039-4365/13/1/7/xml
article pdf uploaded. 17 February 2023 07:58 CET Updated version of record https://www.mdpi.com/2039-4365/13/1/7/pdf
article html file updated 17 February 2023 07:59 CET Original file -
article html file updated 9 March 2023 20:16 CET Update https://www.mdpi.com/2039-4365/13/1/7/html
Back to TopTop